AAAAAA

   
Results: 1-8 |
Results: 8
CEFOPERAZONE SULBACTAM VERSUS CEFOPERAZONE PLUS MEZLOCILLIN - EMPIRICTHERAPY FOR FEBRILE, NEUTROPENIC BONE-MARROW TRANSPLANT PATIENTS/
Authors: LAZARUS HM CREGER RJ GUCALP R FOX RM CIOBANU N CARLISLE PS COOPER BW JACOBS MR
Citation: Hm. Lazarus et al., CEFOPERAZONE SULBACTAM VERSUS CEFOPERAZONE PLUS MEZLOCILLIN - EMPIRICTHERAPY FOR FEBRILE, NEUTROPENIC BONE-MARROW TRANSPLANT PATIENTS/, International journal of antimicrobial agents, 7(2), 1996, pp. 85-91
PILOT-STUDY OF HIGH-DOSE MITOXANTRONE AND BUSULFAN PLUS AUTOLOGOUS BONE TRANSPLANTATION IN PATIENTS WITH ADVANCED MALIGNANCIES
Authors: KHALIL A CIOBANU N SPARANO JA GUCALP R DUTCHER JP WIERNIK PH
Citation: A. Khalil et al., PILOT-STUDY OF HIGH-DOSE MITOXANTRONE AND BUSULFAN PLUS AUTOLOGOUS BONE TRANSPLANTATION IN PATIENTS WITH ADVANCED MALIGNANCIES, Bone marrow transplantation, 15(1), 1995, pp. 93-97
PHASE-I TRIAL OF HIGH-DOSE MELPHALAN, HIGH-DOSE ETOPOSIDE AND AUTOLOGOUS BONE-MARROW RE-INFUSION IN SOLID TUMORS - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP (ECOG) STUDY
Authors: LAZARUS HM GRAY R CIOBANU N WINTER J WEINER RS
Citation: Hm. Lazarus et al., PHASE-I TRIAL OF HIGH-DOSE MELPHALAN, HIGH-DOSE ETOPOSIDE AND AUTOLOGOUS BONE-MARROW RE-INFUSION IN SOLID TUMORS - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP (ECOG) STUDY, Bone marrow transplantation, 14(3), 1994, pp. 443-448
RECOMMENDED GUIDELINES FOR THE MANAGEMENT OF AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION - A REPORT FROM THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP (ECOG)
Authors: ROWE JM CIOBANU N ASCENSAO J STADTMAUER EA WEINER RS SCHENKEIN DP MCGLAVE P LAZARUS HM
Citation: Jm. Rowe et al., RECOMMENDED GUIDELINES FOR THE MANAGEMENT OF AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION - A REPORT FROM THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP (ECOG), Annals of internal medicine, 120(2), 1994, pp. 143-158
SURVIVAL AFTER PHASE-II TREATMENT OF ADVANCED RENAL-CELL CARCINOMA WITH TAXOL OR HIGH-DOSE INTERLEUKIN-2
Authors: WALPOLE ET DUTCHER JP SPARANO J GUCALP R EINZIG A PAIETTA E CIOBANU N GRIMA K CALIENDO G CAVASOTTO G WIERNIK PH
Citation: Et. Walpole et al., SURVIVAL AFTER PHASE-II TREATMENT OF ADVANCED RENAL-CELL CARCINOMA WITH TAXOL OR HIGH-DOSE INTERLEUKIN-2, Journal of immunotherapy with emphasis on tumor immunology, 13(4), 1993, pp. 275-281
COMPARISON OF PREPARATIVE TRANSPLANTATION REGIMENS USING CARMUSTINE ETOPOSIDE CISPLATIN OR BUSULFAN ETOPOSIDE CYCLOPHOSPHAMIDE IN LYMPHOID MALIGNANCIES
Authors: CRILLEY P LAZARUS H TOPOLSKY D CIOBANU N CREGER RJ FOX RM BULOVA SI SHINA DC GUCALP R COOPER BW SOEGIARSO W STYLER M BRODSKY I
Citation: P. Crilley et al., COMPARISON OF PREPARATIVE TRANSPLANTATION REGIMENS USING CARMUSTINE ETOPOSIDE CISPLATIN OR BUSULFAN ETOPOSIDE CYCLOPHOSPHAMIDE IN LYMPHOID MALIGNANCIES, Seminars in oncology, 20(4), 1993, pp. 50-54
DETECTION AND VIABILITY OF TUMOR-CELLS IN PERIPHERAL-BLOOD STEM-CELL COLLECTIONS FROM BREAST-CANCER PATIENTS USING IMMUNOCYTOCHEMICAL AND CLONOGENIC-ASSAY TECHNIQUES
Authors: ROSS AA COOPER BW LAZARUS HM MACKAY W MOSS TJ CIOBANU N TALLMAN MS KENNEDY MJ DAVIDSON NE SWEET D WINTER C AKARD L JANSEN J COPELAN E MEAGHER RC HERZIG RH KLUMPP TR KAHN DG WARNER NE
Citation: Aa. Ross et al., DETECTION AND VIABILITY OF TUMOR-CELLS IN PERIPHERAL-BLOOD STEM-CELL COLLECTIONS FROM BREAST-CANCER PATIENTS USING IMMUNOCYTOCHEMICAL AND CLONOGENIC-ASSAY TECHNIQUES, Blood, 82(9), 1993, pp. 2605-2610
AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) USING EX-VIVO ETOPOSIDE(VP-16) PURGED MARROW IN PATIENTS (PTS) WITH POOR-RISK LYMPHOMAS (LY)AND ACUTE LEUKEMIAS (LEUK)
Authors: CIOBANU N LAZARUS HM DEBELLIS R ASCENSAO J SPARANO JA GUCALP R DUTCHER J FOX RM CREGER RJ COOPER BW GERSON SL NESE M BELLO L WIEMIK PH
Citation: N. Ciobanu et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) USING EX-VIVO ETOPOSIDE(VP-16) PURGED MARROW IN PATIENTS (PTS) WITH POOR-RISK LYMPHOMAS (LY)AND ACUTE LEUKEMIAS (LEUK), Blood, 82(10), 1993, pp. 10000629-10000629
Risultati: 1-8 |